The Cancer Focus Fund is an oncology-focused investment fund which invests in compelling cancer therapies at or near the FDA Phase 1 or Phase 2 human clinical trial regimen. The fund offers business, management, IP, clinical, scientific and regulatory support through experienced and proven professionals.
At the Cancer Focus Fund, we invest in promising therapies in late preclinical development through Phase I and Phase Ib/II clinical trials. Our objective is to provide support to accelerate the development of these therapeutics together with the clinical trials expertise and infrastructure of MD Anderson.
Through our unique approach, we believe the Cancer Focus Fund has the potential to bring more treatments to patients in need while also rewarding our investors.
Company Details
- Employees
- 4
- Address
- 2450 Holcombe Boulevard, Houston,texas 77021,united States
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- http://cancerfocusfund.com/
- Keywords
- New York.
- HQ
- Houston, Texas
Cancer Focus Fund Questions
Cancer Focus Fund's website is http://cancerfocusfund.com/
Cancer Focus Fund's LinkedIn profile is https://www.linkedin.com/company/cancer-focus-fund
Cancer Focus Fund has
4 employees.
View email and phone details for 4
employees at Cancer Focus Fund.
Cancer Focus Fund's industry is
Investment Management
Cancer Focus Fund's top competitors are
Hsbc Innovation Banking,
Genespire,
Modi Ventures,
Oppenheimer & Co. Inc.,
Md Anderson Cancer Center,
Kb Investment,
Biotechtv,
Cancer Prevention And Research Institute Of Texas,
March Biosciences,
Eisbach Bio Gmbh.
Cancer Focus Fund's categories are Investment Management
